Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins. - Wikidata - awgldk - TriplyDB

Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.

Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.

http://www.wikidata.org/entity/Q33886869

about

New developments in anti-malarial target candidate and product profiles Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial Case definition: postartemisinin delayed hemolysis.Efficacy of intravenous methylene blue, intravenous artesunate, and their combination in preclinical models of malaria.An imported case of severe falciparum malaria with prolonged hemolytic anemia clinically mimicking a coinfection with babesiosis.Management of severe paediatric malaria in resource-limited settings.Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013 Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury.Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.Severe falciparum malaria complicated by prolonged haemolysis and rhinomaxillary mucormycosis after parasite clearance: a case report.Imaging flow cytometry for the study of erythroid cell biology and pathology.Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.Artesunate treatment of severe pediatric malaria: A review of parasite clearance kinetics and clinical implications.Anti-Self Phosphatidylserine Antibodies Recognize Uninfected Erythrocytes Promoting Malarial Anemia.Impact of using artemisinin-based combination therapy (ACT) in the treatment of uncomplicated malaria from Plasmodium falciparum in a non-endemic zone.Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.Biomechanics of red blood cells in human spleen and consequences for physiology and disease Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.Intravascular haemolysis with haemoglobinuria in a splenectomized patient with severe Plasmodium knowlesi malaria.Severe malaria in Europe: an 8-year multi-centre observational study.Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments Malaria parasite clearance.Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria - United States, 2008 and 2013.Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine.Therapeutic potential of manipulating suicidal erythrocyte death.High Frequency of Blackwater Fever Among Children Presenting to Hospital With Severe Febrile Illnesses in Eastern Uganda.Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications.Development of Delayed Hemolytic Anemia After Treatment with Oral Artemether-Lumefantrine in Two Patients with Severe Falciparum Malaria.A 41-year-old man with fever and dark-coloured urine.Artesunate-related fever and delayed hemolysis in a returning traveler.Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.Anaemia following Artemisinin-Based Combination Treatments of Uncomplicated Plasmodium falciparum Malaria in Children: Temporal Patterns of Haematocrit and the Use of Uncomplicated Hyperparasitaemia as a Model for Evaluating Late-Appearing Anaemia.Artesunate for Imported Severe Malaria in Nonendemic Countries.A case of blackwater fever with persistent Plasmodium falciparum parasitaemia detected by PCR after artemether-lumefantrine treatment.Blackwater fever in a non-immune patient with Plasmodium falciparum malaria after intravenous artesunate.Spherocytic shift of red blood cells during storage provides a quantitative whole cell-based marker of the storage lesion.A cryptic cycle in haematopoietic niches promotes initiation of malaria transmission and evasion of chemotherapy.Anaemia and malaria

P2860

Q28468598-C7D19DA0-91F4-455F-99A2-6005323D6786 Q28552379-0A03A835-55E2-4844-9644-0297A096799C Q33886840-58DD2CF3-315A-4B37-AD60-53D8F21F3291 Q34409963-76C92394-FE49-4858-BDB2-344F60104B77 Q34775196-1237C218-52DA-4D1D-AEEA-958DA541C44F Q35142564-014D0A02-B31D-4B28-A16D-E11A01BF505A Q35546045-777D521D-9726-4182-862B-1FC0C9DD31BB Q35750308-6583E3B9-4E06-46D9-A3FD-E09BB016EEDE Q35821563-56132596-39E8-4342-B290-11C309396302 Q35860379-A7BB30E4-D864-43DC-B2B8-13D920D7D0E3 Q35908580-AA5366B6-9A87-4D24-8EF8-E7F520A7C26C Q36035590-085B65BA-966F-4B7D-986C-73D21CAB298F Q36277347-D99EC0E4-DE8F-42E7-A8E5-E84977376AC7 Q36883456-820CE36C-8E11-4190-8CDD-0088B52529B6 Q37059579-E9CB79DE-1F15-4D35-882D-044F67E7C480 Q37067888-7C269F78-1497-4840-B539-36D561D88ED3 Q37102400-54131A6F-45B1-4F95-9408-E2712E183873 Q37169837-B23089E7-7B58-43F1-86D2-ACE78672ADFD Q37243860-3EDA684E-7013-49B8-9252-19EB4A1E1CA4 Q37618634-77AD31C5-9FA1-4011-9576-F5A25B5E1134 Q37628066-C0944B8F-E98B-49BA-B23A-8231FD3CE7ED Q37663369-D08B1082-8341-45C9-B566-CB8F96A0CEE8 Q38244208-CF22EE24-5702-4523-B503-7503FD6DE815 Q38372007-3ADC7DC4-CC1B-4679-A975-A0596CBD9874 Q38503447-FC36C179-7949-4AD5-A73D-93F4A8DF7A00 Q38850738-B874FBB6-3E49-4E73-8DBA-1C8C8F7E595F Q39232091-8A18534E-3B78-445E-A888-F313564A3D60 Q39536124-6D95BB78-567D-4394-AD93-2BE9F1894E7B Q40113298-EBD7539B-506D-4668-B7D6-6A480C1D815A Q40121798-6D35820F-B0B8-4469-A4F9-F50688A6E2A8 Q41073549-F66B431D-5A40-4344-98E8-C969B1DACD92 Q41911948-8CC400AE-874D-4768-82D0-84CF76BEEC8A Q46425653-DC14C0BE-155B-483F-B7F2-47840B14C459 Q47929383-DA61D133-1DDA-488D-BCCB-64E348B357E5 Q48022213-6291F85A-8F98-4B40-B3EA-FA3E0F7616C9 Q48024171-EB8EA01E-30EE-4FE2-91DE-D7797CA93743 Q50217417-7C798F06-16F8-41ED-A082-C84D8AFC5229 Q55251296-16B33162-8960-41C5-9476-FF615F89BF0B Q57810771-7BAA7E89-9319-40EF-A0CE-C6EBE8FD1EB7

P2860

Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.

http://www.wikidata.org/entity/Q33886869

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Postartesunate delayed hemolys ...... saving effect of artemisinins.

@ast

Postartesunate delayed hemolys ...... saving effect of artemisinins.

@en

type

label

Postartesunate delayed hemolys ...... saving effect of artemisinins.

@ast

Postartesunate delayed hemolys ...... saving effect of artemisinins.

@en

prefLabel

Postartesunate delayed hemolys ...... saving effect of artemisinins.

@ast

Postartesunate delayed hemolys ...... saving effect of artemisinins.

@en

P1433

Q33886869-233F5AEE-DB18-4C86-A9F2-2CFAB7E47120

P1476

Q33886869-C34EFC5B-4BA4-48F3-B3D4-CF60C21CA83D

P2093

Q33886869-0CBF2141-B8DE-4479-8CD5-2D6492ECFB5F

Q33886869-0D0ADACA-D9ED-4890-80AC-5CFEC5F26C70

Q33886869-113EDD10-99B4-4188-AA25-CBAA1D33D178

Q33886869-3C2A25CF-2ECF-4616-A757-8561AA438622

Q33886869-3F675086-49EB-4779-BDF8-EBD9A662403E

Q33886869-43F8199A-03C6-4BCF-937E-BE3BFD39C26C

Q33886869-700C2F1D-90CE-4494-8932-A0C95B2A2443

Q33886869-7438F5BF-D0FF-4F9A-9889-CE051EFD5AE7

Q33886869-8D59F99B-E24B-4786-B5FC-3C36100864FE

Q33886869-9D31B063-8116-4299-8C5B-CFABA0D2D809

P2860

Q33886869-1B774A4E-DCB6-4720-BAD1-8A945C48DE4E

Q33886869-1C3E91CC-5A5B-4EA8-AE66-74DCE2D482FB

Q33886869-1E6AB1D5-CD22-40A8-8D57-440E0B7C45B1

Q33886869-1EE69BE2-3708-4EF7-9020-E3F6EA433207

Q33886869-31D17D4B-95D1-419A-8B2C-BDB13B0B7F91

Q33886869-3723CE0C-850C-4495-A1C8-6B6B3774AE0F

Q33886869-52D2F235-B3F6-45DB-A864-62776ED5434F

Q33886869-61F50899-07B6-4E6B-A46D-7A824601CD8E

Q33886869-62BB47B7-BF8D-4966-A561-3F29EEEB061C

Q33886869-680F2060-E72A-4D40-913A-7422DA9519F7

P304

Q33886869-0F5E2BE1-0AEB-46C8-B5D2-E88E0F88FA3B

P31

Q33886869-AB16FA1E-8FED-472A-8635-47DBA9C2917F

P356

Q33886869-5F2A2338-5759-4DD8-BE10-B333B24534FC

P407

Q33886869-EA60F197-273A-4723-BC96-EF9996AFAA91

P433

Q33886869-43F7806F-B5B3-42B1-B3E9-88ECA65C3E1D

P478

Q33886869-6F19D801-5611-4514-AFE5-F6C2536CF554

P50

Q33886869-15DE928D-9943-4EF8-9C4C-4608A4BD8E05

Q33886869-1A74E4D6-E664-41C8-A6E0-6FA2407EE25F

Q33886869-2F0EB210-1874-491B-9C1F-B032E405EF0A

Q33886869-4453199E-0450-4591-A5A9-C3D4D28AA119

Q33886869-85D790FA-0E0A-43AB-B3AD-1B80C736D5BF

Q33886869-A8B4376F-CFFB-40E1-9010-FFBE174480C3

Q33886869-AB6F61B4-5AE9-4D0E-874F-DB7EE9145247

P577

Q33886869-32A484CA-63A2-48CB-B1D7-0498D2F57EFC

P5875

Q33886869-B5C8FAA7-D2C4-47B9-B775-C11C1699ED13

P698

Q33886869-B80ADC0E-38B3-4A28-99B7-98A1E1FDBC72

P921

Q33886869-A6ED9AB3-6916-4286-81C5-FB1287780B9F

Q33886869-D958709B-6F7A-4C36-93D9-DEC5D5B0AA97

P932

Q33886869-C97C37C8-703A-43DD-A80E-673B009D6690

P356

BLOOD-2014-02-555953

P1433

P1476

Postartesunate delayed hemolys ...... saving effect of artemisinins.

@en

P2093

Adéla Angoulvant

http://www.w3.org/2001/XMLSchema#string

Camille Roussel

http://www.w3.org/2001/XMLSchema#string

Dominique Mazier

http://www.w3.org/2001/XMLSchema#string

Eric Caumes

http://www.w3.org/2001/XMLSchema#string

Flavie Ader

http://www.w3.org/2001/XMLSchema#string

French Artesunate Working Group

http://www.w3.org/2001/XMLSchema#string

Innocent Safeukui

http://www.w3.org/2001/XMLSchema#string

Julien Mayaux

http://www.w3.org/2001/XMLSchema#string

Kasturi Haldar

http://www.w3.org/2001/XMLSchema#string

Liliane Ciceron

http://www.w3.org/2001/XMLSchema#string

P2860

Artesunate versus quinine for treating severe malaria

Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium.

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

The anaemia of Plasmodium vivax malaria

Surface area loss and increased sphericity account for the splenic entrapment of subpopulations of Plasmodium falciparum ring-infected erythrocytes

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

Assessment of coma and impaired consciousness. A practical scale

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.

Ex vivo perfusion of human spleens maintains clearing and processing functions.

Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.

P304

167-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-02-555953

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

François Bricaire

Papa Alioune Ndour

Stéphane Jauréguiberry

P577

2014-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262611655

http://www.w3.org/2001/XMLSchema#string

P698

24859359

http://www.w3.org/2001/XMLSchema#string

P921

P932

4093678

http://www.w3.org/2001/XMLSchema#string